Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Glioblastoma 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Stomatitis 1Stomach Neoplasms 1Solid Tumor Refractory to Standard Therapy 1Sarcoma 1Precancerous Conditions 1Pancreatic Neoplasms 1Ototoxicity 1Mycosis Fungoides 1Mucositis 1Mouth Neoplasms 1Meningioma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Leiomyoma 1Hodgkin Disease 1Hearing Loss 1Head and Neck Neoplasms 1Gliosarcoma 1Fatigue 1Dermatomyositis 1Breast Neoplasms 1Brain Neoplasms 1Anemia 1

Interventions

cabozantinib 1Specimen Handling 1Sodium Chloride 1Platinum Compounds 1Nivolumab 1Ipilimumab 1Etanercept 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Dermatomyositis × Sodium Chloride × Clear all
NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed
16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡